St Andrews-based investment firm Eos Advisory has entered into a strategic partnership with US-based Kineticos Life Sciences to co-invest in early stage Scottish life sciences companies.
The venture partnership aims to invest over £10m over the next five years in oncology-focused life sciences ventures founded in Scotland.
Headquartered in Raleigh, North Carolina, Kineticos has a biotech advisory practice and a related fund to invest in the advancement and commercialisation of clinical research.
As part of the deal, Eos will engage with Scottish Enterprise and a range of other private and public investors to leverage its co-investments.
Specifically, the partnership will seek out Scottish-based investment opportunities that address large, unmet medical needs in oncology, neurosciences and rare diseases, new approaches to gene and cell therapies, and precision medicine technologies.
Read more HERE.
